Oncology PracticeAI in Clinical Dermatology: Consider Limitations, Current IssuesMarch 22, 2024Business of MedicineNonmelanoma Skin CancerMelanoma
Oncology PracticeNon-Radical Surgery a Win-Win for Early Cervical CancerMarch 20, 2024Gynecologic CancerGenitourinary CancerPatient & Survivor CareMixed Topics
Oncology PracticeQOL Not Harmed With Add-On Pembrolizumab in Cervical CancerMarch 19, 2024Gynecologic CancerPatient & Survivor Care
Oncology PracticeRUBY: ‘A Huge Win’ for Patients With Advanced or Recurrent Endometrial CancerMarch 18, 2024Gynecologic CancerPatient & Survivor Care
Hematology NewsHigh Marks for New CAR T Toxicity Grading ToolMarch 12, 2024Cellular TherapyB Cell LymphomaDLBCLMantle Cell LymphomaMultiple MyelomaTransplantMixed Topics
Oncology PracticeLatest NCCN Melanoma Guidelines Capture Dynamic of Constantly Evolving Best PracticeMarch 11, 2024Melanoma
Hematology NewsMM:New Tool Gauges Post–CAR T Relapse RiskFebruary 29, 2024Multiple MyelomaCellular Therapy
Oncology PracticeExpert Hopes to Expand Ohio Model of Melanoma Case ReportingFebruary 13, 2024MelanomaBusiness of Medicine
Oncology PracticeRegrowth Predicts Metastasis in Rectal Cancer Watch and WaitFebruary 8, 2024GastroenterologyPatient & Survivor CareGastrointestinal Cancer
Oncology PracticeMore Than 100K New Cutaneous Melanoma Diagnoses Expected in 2024February 5, 2024Melanoma
Oncology PracticeSmall PFS gain in metastatic prostate cancer with TKI and ICIJanuary 31, 2024Genitourinary CancerImmunotherapyPatient & Survivor CareProstate Cancer
Oncology PracticeCombo Tx Best in Metastatic Prostate Cancer with HRR MutationsJanuary 31, 2024Genitourinary CancerPatient & Survivor CareProstate Cancer
Oncology PracticeStockholm3 Prostate Test Bests PSA for Prostate Cancer Risk in North AmericaJanuary 30, 2024Genitourinary CancerPractice ManagementPreventive Care